Prostate cancer drug ruling a 'fiasco', says charity
A charity says a decision by the NHS in England to reject a drug for men with prostate cancer is a "fiasco".
Abiraterone is already given to patients at the end-of-life after chemotherapy as it gives patients an extra few months.
But the National Institute for Health and Care Excellence said it was not cost-effective to be offered before.
BBC health correspondent Dominic Hughes reports.
15 Aug 2014
- From the section Health